| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -12.85 | -63.52 | -61.23 | -46.5 |
Depreciation | -26.57 | -26.9 | -57.04 | -66.14 |
Tax paid | -1.56 | -17.09 | -10.64 | 11.38 |
Working capital | -357.74 | 386.41 | -54.89 | 14.93 |
Other operating items | ||||
Operating | -398.72 | 278.87 | -183.81 | -86.33 |
Capital expenditure | -12.4 | -637.13 | 5.57 | 18.8 |
Free cash flow | -411.12 | -358.25 | -178.23 | -67.52 |
Equity raised | 1,403.09 | 1,412.19 | 913 | 1,023.66 |
Investing | -2.28 | -342.33 | 0 | -49.78 |
Financing | 107.44 | -786.45 | 63.01 | 116.85 |
Dividends paid | 0 | 0 | 0 | 0 |
Net in cash | 1,097.12 | -74.84 | 797.78 | 1,023.2 |
Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.
Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
